Clinical Trial Update: SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing valproate–amisulpride versus valproate–haloperidol in patients with Bipolar I disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Amisulpride (amisulpride)
• HALOPERIDOL (HALOPERIDOL LACTATE)
• Valproate (valproate)

Snippet

Sponsor: Sanofi | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED